Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Capital Leases: 2014-2018

Historic Capital Leases for Zevra Therapeutics (ZVRA) over the last 2 years, with Dec 2018 value amounting to $396,000.

  • Zevra Therapeutics' Capital Leases was N/A to $396,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $396,000, marking a year-over-year change of. This contributed to the annual value of $396,000 for FY2018, which is N/A change from last year.
  • Zevra Therapeutics' Capital Leases amounted to $396,000 in FY2018, which was up 1,423.08% from $26,000 recorded in FY2014.
  • Zevra Therapeutics' Capital Leases' 5-year high stood at $396,000 during FY2018, with a 5-year trough of $26,000 in FY2014.
  • Over the past 1 years, Zevra Therapeutics' median Capital Leases value was $396,000 (recorded in 2018), while the average stood at $396,000.